#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiomyopathy Arterial disorder Barth syndrome Adenovirus infection Amyotrophic lateral sclerosis Alveolar proteinosis Severe myoclonic epilepsy of infancy Oropharyngeal squamous cell carcinoma Cutaneous T-cell lymphoma stage I Neoplasm malignant Ehlers-Danlos syndrome Haemophilia A with anti factor VIII Cold type haemolytic anaemia Hereditary optic atrophy Hepatoblastoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Trials in Disease Cystic fibrosis lung – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information KBG syndrome – Basic Information Methylmalonic acidaemia – Trials in Disease Friedreich’s ataxia – Basic Information Paroxysmal nocturnal haemoglobinuria – Life with Disease Sarcoidosis – Life with Disease Rhabdomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Budesonide Treg02 Dersimelagon Phosphate Formoterol Fumarate Dihydrate NALDEMEDINE Zanamivir Aspergillus Fumigatus Oxygen Ph.eur. Aptamer-4Ft Micafungin 2,4 DICHLOROBENZYL ALCOHOL Esomeprazole Magnesium Cefazolin Sodium Nicotine FLUORIDE AGA2118 Alternaria Alternata Extract Daptomycin Hexaminolevulinate Barzolvolimab More therapies…

    Learn about Your Condition

    Endometrial cancer stage III Diabetic autonomic neuropathy Laryngeal cancer stage III Multiple sclerosis Epidermolysis bullosa Appendicitis Meniscus operation Breast cancer stage II Plasma cell myeloma refractory Paresis Haemoglobinuria Mucopolysaccharidosis III Systemic sclerosis pulmonary Alcoholic liver disease Pulmonary hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Tuberous sclerosis complex

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    3 1
    Investigated Drugs:
    • Cannabidiol
    • Dronabinol
    Spain

  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    4 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Vigabatrin
    • Sirolimus
    Poland

  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carbamazepine
    • Diazepam
    • Midazolam Hydrochloride
    Austria Germany

  • Study on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures

    Not recruiting

    2 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Basimglurant
    Italy Poland Spain

  • Long-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Everolimus
    Poland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!